We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

39 hedge funds and large institutions have $5.55M invested in Zomedica Corp. in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

11% more funds holding

Funds holding: 35 → 39 (+4)

33% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 12

71% less capital invested

Capital invested by funds: $19.5M → $5.55M (-$13.9M)

Holders
39
Holders Change
+4
Holders Change %
+11.43%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
12
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SG Americas Securities
SG Americas Securities
New York
+$48.3K
2
Citadel Advisors
Citadel Advisors
Florida
+$29K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$26.2K
4
Goldman Sachs
Goldman Sachs
New York
+$24K
5
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
+$11.1K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$66.6K
2
BlackRock
BlackRock
New York
-$22.3K
3
SPC
Sigma Planning Corp
Michigan
-$17K
4
Invesco
Invesco
Georgia
-$16K
5
Bank of America
Bank of America
North Carolina
-$13.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Cambridge Investment Research Advisors
1
Cambridge Investment Research Advisors
Iowa
$4.23M – – –
BlackRock
2
BlackRock
New York
$610K -$22.3K -25,262 -1%
State Street
3
State Street
Massachusetts
$157K +$2.73K +3,100 +0.7%
Northern Trust
4
Northern Trust
Illinois
$123K -$1.12K -1,274 -0.4%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$58K +$26.2K +29,709 +22%
Vanguard Group
6
Vanguard Group
Pennsylvania
$56K +$10.8K +12,259 +8%
Wells Fargo
7
Wells Fargo
California
$26K -$1.18K -1,332 -2%
Charles Schwab
8
Charles Schwab
California
$26K – – –
Bank of New York Mellon
9
Bank of New York Mellon
New York
$25K – – –
California State Teachers Retirement System (CalSTRS)
10
California State Teachers Retirement System (CalSTRS)
California
$23K – – –
TCIM
11
TIAA CREF Investment Management
New York
$21K – – –
JA
12
JVL Associates
Michigan
$20K – – –
State of Wisconsin Investment Board
13
State of Wisconsin Investment Board
Wisconsin
$19K +$11.1K +12,600 +30%
SG Americas Securities
14
SG Americas Securities
New York
$19K +$48.3K +54,776 New
Citadel Advisors
15
Citadel Advisors
Florida
$18K +$29K +32,883 +188%
Deutsche Bank
16
Deutsche Bank
Germany
$17K -$335 -380 -0.7%
TA
17
Teachers Advisors
New York
$17K – – –
RhumbLine Advisers
18
RhumbLine Advisers
Massachusetts
$16K -$913 -1,035 -2%
New York State Common Retirement Fund
19
New York State Common Retirement Fund
New York
$14K – – –
AIG
20
American International Group
New York
$10K +$870 +986 +4%
Goldman Sachs
21
Goldman Sachs
New York
$10K +$24K +27,239 New
PPA
22
Parametric Portfolio Associates
Washington
$5K -$164 -186 -1%
JP Morgan Chase
23
JP Morgan Chase
New York
$4K -$4.25K -4,821 -31%
SO
24
STRS Ohio
Ohio
$4K – – –
Citigroup
25
Citigroup
New York
$4K +$8.6K +9,749 +401%
1
2

ZOM Hedge Fund Activity: Q1 2019 in Review

39 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q1 2019, worth a combined $5.55M — down 71% from $19.5M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ZOM positions and 2 closed out — a net gain of 4 holders — while 8 added to existing stakes and 12 trimmed.

The largest buyer was SG Americas Securities, opening a new position worth an estimated $48.3K. The largest seller was Morgan Stanley, cutting an estimated $66.6K.

  • 39 institutional investors held Zomedica Corp. (ZOM) as of Q1 2019, up from 35 in Q4 2018.
  • Funds reported $5.55M of Zomedica Corp. stock for Q1 2019, down 71% quarter-over-quarter.
  • 6 funds opened new Zomedica Corp. positions in Q1 2019 and 2 closed out, a net change of +4 holders.
  • The largest Zomedica Corp. buyer in Q1 2019 was SG Americas Securities, an estimated $48.3K added.
  • The largest Zomedica Corp. seller in Q1 2019 was Morgan Stanley, an estimated $66.6K sold.

Based on aggregated 13F filings for Q1 2019.